Quest Diagnostics (NYSE:DGX) Given New $190.00 Price Target at Truist Financial
Quest Diagnostics (NYSE:DGX – Free Report) had its target price lifted by Truist Financial from $182.00 to $190.00 in a report released on Wednesday,Benzinga reports. They currently have a hold rating on the medical research company’s stock. A number of other brokerages have also commented on DGX. Redburn Atlantic initiated coverage on Quest Diagnostics in […]
Quest Diagnostics (NYSE:DGX – Free Report) had its target price lifted by Truist Financial from $182.00 to $190.00 in a report released on Wednesday,Benzinga reports. They currently have a hold rating on the medical research company’s stock. A number of other brokerages have also commented on DGX. Redburn Atlantic initiated coverage on Quest Diagnostics in […]
